• LAST PRICE
    26.1900
  • TODAY'S CHANGE (%)
    Trending Down-0.2200 (-0.8330%)
  • Bid / Lots
    26.2000/ 1
  • Ask / Lots
    26.8800/ 1
  • Open / Previous Close
    26.4000 / 26.4100
  • Day Range
    Low 26.1500
    High 26.4800
  • 52 Week Range
    Low 26.1500
    High 42.7200
  • Volume
    356,594
    below average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Thursday's close: 26.41
TimeVolumeGMAB
09:32 ET391726.43
09:34 ET162726.44
09:36 ET10026.45
09:38 ET88926.45
09:39 ET77526.45
09:41 ET269026.48
09:43 ET115826.45
09:45 ET395026.385
09:48 ET20026.36
09:52 ET93026.32
09:54 ET30726.345
09:56 ET60026.35
09:57 ET95026.36
09:59 ET60026.35
10:01 ET60026.36
10:03 ET20026.35
10:06 ET176526.32
10:08 ET56226.3108
10:10 ET177526.2901
10:12 ET113126.2911
10:14 ET216026.2571
10:15 ET250026.2799
10:17 ET120026.27
10:19 ET421426.2899
10:21 ET70026.26
10:24 ET10026.28
10:26 ET192026.26
10:28 ET90726.27
10:30 ET667426.265
10:32 ET255026.23
10:35 ET74026.22
10:37 ET159326.21
10:39 ET480226.2
10:42 ET270226.19
10:44 ET532826.18
10:46 ET265526.22
10:48 ET260126.25
10:50 ET10026.26
10:51 ET116526.25
10:53 ET81826.28
10:55 ET127326.29
10:57 ET170026.25
11:00 ET10026.29
11:04 ET10026.28
11:06 ET52326.29
11:11 ET20026.27
11:15 ET36026.275
11:18 ET20026.27
11:20 ET20026.26
11:22 ET40026.26
11:24 ET20026.23
11:26 ET50426.26
11:27 ET30026.28
11:29 ET179226.3
11:33 ET58426.305
11:36 ET10026.32
11:38 ET70026.3
11:40 ET25026.31
11:42 ET50026.3
11:44 ET613726.335
11:47 ET268526.32
11:49 ET146926.315
11:51 ET343426.29
11:54 ET64126.29
11:56 ET365426.3016
11:58 ET32726.32
12:00 ET30026.3222
12:02 ET50026.3
12:03 ET105126.27
12:05 ET105026.26
12:07 ET50026.24
12:09 ET133426.255
12:12 ET60026.28
12:16 ET90926.26
12:18 ET10026.25
12:20 ET95726.255
12:25 ET41226.2599
12:27 ET40026.25
12:30 ET21326.22
12:32 ET10026.22
12:34 ET169226.2
12:36 ET29626.22
12:38 ET10026.22
12:39 ET221026.23
12:43 ET20026.25
12:48 ET70226.22
12:50 ET30126.22
12:52 ET41826.21
12:54 ET10026.2
12:57 ET83226.21
01:01 ET10026.21
01:06 ET50026.205
01:08 ET114326.22
01:10 ET12026.22
01:14 ET60026.23
01:15 ET77126.23
01:17 ET116526.2245
01:19 ET263426.22
01:21 ET20526.23
01:24 ET120026.215
01:26 ET80026.2
01:28 ET47326.2
01:30 ET10926.205
01:32 ET166626.18
01:33 ET25826.18
01:35 ET70026.19
01:37 ET119126.2
01:42 ET100026.2
01:44 ET20026.2
01:46 ET30026.18
01:48 ET122626.2
01:51 ET35026.21
01:53 ET40026.195
01:55 ET219926.19
01:57 ET166226.17
02:00 ET10026.17
02:02 ET39226.17
02:04 ET277726.1576
02:06 ET131926.17
02:08 ET73526.2025
02:11 ET20026.2
02:13 ET101426.19
02:18 ET246326.18
02:20 ET60026.209
02:22 ET20026.2
02:26 ET270626.2226
02:27 ET126326.25
02:29 ET50026.23
02:31 ET40026.22
02:33 ET10026.23
02:36 ET40026.22
02:38 ET20026.21
02:40 ET48626.215
02:42 ET30026.21
02:44 ET20026.21
02:45 ET54026.22
02:47 ET10026.23
02:49 ET130026.24
02:54 ET20026.26
02:56 ET13126.27
02:58 ET90026.24
03:00 ET16326.24
03:02 ET10026.24
03:03 ET20026.25
03:05 ET16226.24
03:07 ET151626.27
03:09 ET30026.28
03:12 ET149126.25
03:14 ET315926.2403
03:16 ET100326.23
03:18 ET126326.25
03:20 ET250726.25
03:21 ET40026.24
03:23 ET98426.25
03:25 ET128526.26
03:27 ET168526.26
03:30 ET40026.25
03:32 ET172026.25
03:34 ET130726.245
03:36 ET20026.24
03:38 ET280026.24
03:39 ET52626.235
03:41 ET206426.26
03:43 ET133026.26
03:45 ET73926.26
03:48 ET40326.255
03:50 ET151226.275
03:52 ET354326.22
03:54 ET80926.22
03:56 ET665026.195
03:57 ET584526.19
03:59 ET6180926.19
Data delayed at least 15 minutes.
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesGMAB
Genmab A/S
17.4B
22.0x
+22.71%
United StatesDNLI
Denali Therapeutics Inc
3.0B
-21.5x
---
United StatesADMA
ADMA Biologics Inc
2.5B
-521.1x
---
United StatesBEAM
Beam Therapeutics Inc
2.0B
-14.3x
---
United StatesTGTX
TG Therapeutics Inc
2.6B
75.1x
---
United StatesGLPG
Galapagos NV
1.7B
51.0x
---
As of 2024-06-16

Company Information

Genmab A/S is a Denmark-based international biotechnology company. It specializes in the creation and development of antibody therapeutics for the treatment of cancer. The Company is the creator of the approved antibodies: DARZALEX (daratumumab) for the treatment of certain multiple myeloma indications, Kesimpta for the treatment of adults with relapsing forms of multiple sclerosis, TEPEZZA (teprotumumab) for the treatment of thyroid eye disease and FASPRO, for the treatment of adult patients with certain multiple myeloma indications. The first approved Genmab created therapy Arzerra, approved for the treatment of certain chronic lymphocytic leukemia indications, is available in Japan and is also available in other territories via compassionate use or oncology access programs. Genmab develops a broad clinical and pre-clinical product pipeline, and owns four antibody technologies, DuoBody bispecific platform, HexaBody platform, DuoHexaBody platform & HexElect platform.

Contact Information

Headquarters
Carl Jacobsens Vej 30KOEBENHAVN V, Denmark 2500
Phone
---
Fax
---

Executives

Independent Chairman of the Board
Deirdre Connelly
President, Chief Executive Officer
Jan Van De Winkel
Independent Deputy Chairman of the Board
Pernille Erenbjerg
Chief Financial Officer, Executive Vice President
Anthony Pagano
Chief Operating Officer, Executive Vice President
Anthony Mancini

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$17.4B
Revenue (TTM)
$2.5B
Shares Outstanding
661.3M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
0.98
EPS
$1.19
Book Value
$6.94
P/E Ratio
22.0x
Price/Sales (TTM)
6.8
Price/Cash Flow (TTM)
---
Operating Margin
32.00%
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.